DB

Dina Burkitbayeva

North America, California, United States, San Francisco

Description

Dina Burkitbayeva is the CEO and Co-Founder of Freedom Biosciences. She previously worked at Product School as a Head Of Growth and Business...

Investor Profile

Dina Burkitbayeva has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dina Burkitbayeva frequently co-invest with?

Arkitekt Ventures
North America, New York, United States, New York
Co-Investments: 1
Boost VC
North America, California, United States, San Mateo
Co-Investments: 1
SV Angel
North America, California, United States, San Francisco
Co-Investments: 1
Lux Capital
North America, New York, United States, New York
Co-Investments: 1
Maverick Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Village Global
North America, California, United States, Covina
Co-Investments: 1
Threshold
North America, California, United States, Menlo Park
Co-Investments: 1

Which angels does Dina Burkitbayeva often collaborate with?

CH
North America, Nevada, United States, Reno
Shared Deals: 1
AZ
North America, California, United States, San Francisco
Shared Deals: 1
AY
North America, District of Columbia, United States, Washington
Shared Deals: 1
BT
North America, California, United States, San Francisco
Shared Deals: 1
CM
North America, California, United States, San Francisco
Shared Deals: 1
EC
North America, California, United States, San Francisco
Shared Deals: 1
AD
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
Shared Deals: 1
Alyssa Atkins
North America, Ontario, Canada, Toronto
Shared Deals: 1
Deon Nicholas
North America, California, United States
Shared Deals: 1

What are some of recent deals done by Dina Burkitbayeva?

HumanFirst

San Francisco, California, United States

HumanFirst accelerates the adoption of patient-centered clinical trials using precision digital measures (e.g., digital biomarkers and eCOA)

Health Care
Series AMay 31, 2021
Amount Raised: $12,000,000